19,99 €
inkl. MwSt.
Versandfertig in 6-10 Tagen
10 °P sammeln
Andere Kunden interessierten sich auch für
![The Value of Tc-MIBI Washout Rate in Detection of Myocardial Ischemia]( "The Value of Tc-MIBI Washout Rate in Detection of Myocardial Ischemia")
The Value of Tc-MIBI Washout Rate in Detection of Myocardial Ischemia23,99 €![Il valore del tasso di washout della Tc-MIBI nel rilevamento dell'ischemia miocardica]( "Il valore del tasso di washout della Tc-MIBI nel rilevamento dell'ischemia miocardica")
Il valore del tasso di washout della Tc-MIBI nel rilevamento dell'ischemia miocardica23,99 €![O valor da taxa de washout do Tc-MIBI na deteção de isquemia miocárdica]( "O valor da taxa de washout do Tc-MIBI na deteção de isquemia miocárdica")
O valor da taxa de washout do Tc-MIBI na deteção de isquemia miocárdica23,99 €![Recurrence of Soft Tissue Sarcomas After Surgical Treatment]( "Recurrence of Soft Tissue Sarcomas After Surgical Treatment")
Recurrence of Soft Tissue Sarcomas After Surgical Treatment19,99 €![Soft tissue sarcomas of the limbs]( "Soft tissue sarcomas of the limbs")
Soft tissue sarcomas of the limbs40,99 €![Valeur du taux de lavage du Tc-MIBI dans la détection de l'ischémie myocardique]( "Valeur du taux de lavage du Tc-MIBI dans la détection de l'ischémie myocardique")
Valeur du taux de lavage du Tc-MIBI dans la détection de l'ischémie myocardique23,99 €![Der Wert der Tc-MIBI-Auswaschrate bei der Erkennung einer Myokardischämie]( "Der Wert der Tc-MIBI-Auswaschrate bei der Erkennung einer Myokardischämie")
Der Wert der Tc-MIBI-Auswaschrate bei der Erkennung einer Myokardischämie35,90 €
Neoadjuvant therapy is employed before the primary treatment of sarcomas. It is not uncommon that it fails due to multi-drug resistance gene causing unnecessary delays in surgery. Tc-99m MIBI, a radiopharmaceutical, is taken-up in these tumours. Being substrate of P-glycoprotein (Pgp), its washout from the malignant tissue may predict the response of sarcoma to neoadjuvant therapy. This book presents the author s experience of in-vivo quantitative estimation of the washout rates of Tc-99m MIBI from nuclear medicine scans of various bone and soft-tissue sarcomas. These rates were then assessed for their ability to predict the effectiveness of neoadjuvant therapy initiated afterwards.